Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease

被引:1
|
作者
Lozano-Sanroma, Javier [1 ]
Barros, Alberto [1 ]
Alcalde, Ignacio [1 ,2 ]
Alvarado-Villacorta, Rosa [1 ]
Sanchez-Avila, Ronald M. [3 ]
Queiruga-Pineiro, Juan [1 ]
Cueto, Luis Fernandez-Vega [1 ,2 ]
Anitua, Eduardo [3 ]
Merayo-Lloves, Jesus [1 ,2 ]
机构
[1] Inst Univ Fernandez Vega, Fdn Invest Oftalmol, Oviedo 33012, Spain
[2] Univ Oviedo, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo 33011, Spain
[3] Biotechnol Inst BTI, Regenerat Med Lab, Vitoria 01007, Spain
关键词
congenital aniridia; plasma rich in growth factors; PRGF; ocular redness; DED; OCULAR SURFACE; AUTOLOGOUS SERUM; DROPS; KERATOPATHY; MANAGEMENT; SYMPTOMS; EYEDROPS; REDNESS; INDEX; SIGNS;
D O I
10.3390/diseases12040076
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Congenital aniridia is a rare bilateral ocular malformation characterized by the partial or complete absence of the iris and is frequently associated with various anomalies, including keratopathy, cataract, glaucoma, and foveal and optic nerve hypoplasia. Additionally, nearly 50% of individuals with congenital aniridia experience symptoms of ocular dryness. Traditional treatment encompasses artificial tears and autologous serum. This study aimed to assess the effectiveness and safety of using platelet rich in growth factors (PRGF) plasma in patients with congenital aniridia and ocular dryness symptoms. Methods: The included patients underwent two cycles of a 3-month PRGF treatment. At 6 months, symptomatology was evaluated using the OSDI and SANDE questionnaires, and ocular surface parameters were analyzed. Results: The OSDI and SANDE values for frequency and severity demonstrated statistically significant improvements (p < 0.05). Ocular redness, corneal damage (corneal staining), and tear volume (Schirmer test) also exhibited statistically significant improvements (p < 0.05). No significant changes were observed in visual acuity or in the grade of meibomian gland loss. Conclusion: The use of PRGF in patients with congenital aniridia and ocular dryness symptoms led to significant improvements in symptomatology, ocular redness, and ocular damage. No adverse effects were observed during the use of PRGF.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Nerve growth factor for dry eye
    Coassin, M.
    Sgrulletta, R.
    Lambiase, A.
    Bonini, S.
    ISOPT: PROCEEDINGS OF THE 6TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, : 5 - +
  • [22] Plasma Rich in Growth Factors (PRGF) compared with Autologous Serum for Dry Eye Treatment
    Valdez Payan, Edna Lucia
    Fernandez, Oscar
    Velasco, Regina
    Baca, Oscar
    Babayan, Alejandro
    Pacheco Del Valle, Cristina
    Dessire Alegria, Elisa
    Robles-Contreras, Atzin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [23] Efficacy of topical nerve growth factor treatment in dogs affected by dry eye
    Coassin, M
    Lambiase, A
    Costa, N
    De Gregorio, A
    Sgrulletta, R
    Sacchetti, M
    Aloe, L
    Bonini, S
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (02) : 151 - 155
  • [24] Therapeutic efficacy of fibroblast growth factor 10 in a rabbit model of dry eye
    Zheng, Wenjing
    Ma, Mingming
    Du, Ergang
    Zhang, Zhengwei
    Jiang, Kelimu
    Gu, Qing
    Ke, Bilian
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 7344 - 7350
  • [25] Efficacy of topical nerve growth factor treatment in dogs affected by dry eye
    Marco Coassin
    Alessandro Lambiase
    Nicola Costa
    Alessandra De Gregorio
    Roberto Sgrulletta
    Marta Sacchetti
    Luigi Aloe
    Stefano Bonini
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, 243 : 151 - 155
  • [26] The Efficacy and Safety of Chinese Eye Exercise of Acupoints in Dry Eye Patients: A Randomized Controlled Trial
    Leedasawat, Pavasut
    Sangvatanakul, Paradi
    Tungsukruthai, Parunkul
    Kamalashiran, Chuntida
    Phetkate, Pratya
    Patarajierapun, Promporn
    Sriyakul, Kusuma
    COMPLEMENTARY MEDICINE RESEARCH, 2024, 31 (02) : 149 - 159
  • [27] Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjögren’s syndrome: a randomized trial
    Min-Ji Kang
    Jee Hye Lee
    Jehyung Hwang
    So-Hyang Chung
    Scientific Reports, 13
  • [28] Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjögren's syndrome: a randomized trial
    Kang, Min-Ji
    Lee, Jee Hye
    Hwang, Jehyung
    Chung, So-Hyang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] Efficacy of 100% autologous platelet-rich plasma and 100% autologous serum in dry eye disease: a randomised controlled trial
    Jongkhajornpong, Passara
    Lekhanont, Kaevalin
    Rattanasiri, Sasivimol
    Numthavaj, Pawin
    McKay, Gareth
    Attia, John
    Thakkinstian, Ammarin
    BMJ OPEN OPHTHALMOLOGY, 2024, 9 (01):
  • [30] Efficacy of Hypotonic 0.18% Sodium Hyaluronate Eye Drops in Patients With Dry Eye Disease
    Lee, Hyo Seok
    Ji, Yong Sok
    Yoon, Kyung Chul
    CORNEA, 2014, 33 (09) : 946 - 951